Deslorat

By: MedicScientist
July 20
0 Comments
Antihistamine

Article Contents ::

Details About Generic Salt ::  Deslorat

Main Medicine Class:: Antihistamine   

(dess-lore-AT-ah-deen)
Clarinex
Tablets
5 mg
Class: Antihistamine

 

 Action Long-acting histamine antagonist with selective H1-receptor histamine antagonist activity.

 

 Indications Relief of nasal and non-nasal symptoms of seasonal and perennial allergic rhinitis; in chronic idiopathic urticaria for relief of symptoms of pruritus and reduction in number and size of hives.

 

 Contraindications Standard considerations.

 

 Route/Dosage

Adults and Children Older Than 12 Yr: PO 5 mg once daily. In patients with renal or hepatic impairment, start with 5 mg qod.

 

 Interactions None well documented.

 

 Lab Test Interferences None well documented.

 

 Adverse Reactions CARDIOVASCULAR: Tachycardia. CNS: Somnolence; fatigue; dizziness. EENT: Pharyngitis; dry throat. GI: Dry mouth; nausea. HEPATIC: Elevated liver enzymes and bilirubin. OTHER: Flu-like symptoms; myalgia; hypersensitivity.

 

 Precautions

Pregnancy: Category C. Lactation: Excreted in breast milk. Children: Safety and efficacy not established in children less than 12 yr. Elderly: Select dose with caution, reflecting greater frequency of decreased hepatic, renal, or cardiac function and comorbidity. Renal or Hepatic Impairment: Dosage adjustment is recommended.

PATIENT CARE CONSIDERATIONS

 

 Administration/Storage

  • Give once daily without regard to food.
  • Start patients with kidney or liver impairment on 1 tablet qod.
  • Store tablets at controlled room temperature. Keep container tightly closed. Protect unit-dose hospital pack from moisture.

 

 Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies. Note history of hepatic or renal dysfunction.
  • Assess for allergy symptoms (eg, rhinitis, nasal congestion, sneezing, itching, watery eyes) before and periodically throughout therapy.
  • Monitor patient for dizziness and excessive drowsiness. If noted, hold therapy and notify health care provider.
OVERDOSAGE: SIGNS & SYMPTOMS
  Increased heart rate and corrected QT interval

 

 Patient/Family Education

  • Explain name, dose, action, and potential side effects of drug.
  • Advise patient to take once daily without regard to meals.
  • Advise patient that if allergy symptoms are not controlled, not to increase the dose of medication or frequency of use but to inform the health care provider. Inform patient that larger or more frequent dosing does not increase effectiveness and may cause drowsiness.
  • Caution patient not to take any otc antihistamines while taking this medication unless advised to do so by the health care provider.
  • If patient is to have allergy skin testing, advise to not take the medication for 6 days or more before the skin testing.
  • Advise patient to notify health care provider if becoming pregnant, planning on becoming pregnant, or breastfeeding.
  • Instruct patient to stop taking drug and immediately report any of the following symptoms to health care provider: dizziness, excessive drowsiness.
  • Caution patient to not take any prescription or otc medications, or dietary supplements unless advised by health care provider.

 

Drugs Class ::

(dess-lore-AT-ah-deen)
Clarinex
Tablets
5 mg
Class: Antihistamine

 

 Action Long-acting histamine antagonist with selective H1-receptor histamine antagonist activity.

 

 Indications Relief of nasal and non-nasal symptoms of seasonal and perennial allergic rhinitis; in chronic idiopathic urticaria for relief of symptoms of pruritus and reduction in number and size of hives.

 

 Contraindications Standard considerations.

 

 Route/Dosage

Adults and Children Older Than 12 Yr: PO 5 mg once daily. In patients with renal or hepatic impairment, start with 5 mg qod.

 

 Interactions None well documented.

 

 Lab Test Interferences None well documented.

 

 Adverse Reactions CARDIOVASCULAR: Tachycardia. CNS: Somnolence; fatigue; dizziness. EENT: Pharyngitis; dry throat. GI: Dry mouth; nausea. HEPATIC: Elevated liver enzymes and bilirubin. OTHER: Flu-like symptoms; myalgia; hypersensitivity.

 

 Precautions

Pregnancy: Category C. Lactation: Excreted in breast milk. Children: Safety and efficacy not established in children less than 12 yr. Elderly: Select dose with caution, reflecting greater frequency of decreased hepatic, renal, or cardiac function and comorbidity. Renal or Hepatic Impairment: Dosage adjustment is recommended.

PATIENT CARE CONSIDERATIONS

 

 Administration/Storage

  • Give once daily without regard to food.
  • Start patients with kidney or liver impairment on 1 tablet qod.
  • Store tablets at controlled room temperature. Keep container tightly closed. Protect unit-dose hospital pack from moisture.

 

 Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies. Note history of hepatic or renal dysfunction.
  • Assess for allergy symptoms (eg, rhinitis, nasal congestion, sneezing, itching, watery eyes) before and periodically throughout therapy.
  • Monitor patient for dizziness and excessive drowsiness. If noted, hold therapy and notify health care provider.
OVERDOSAGE: SIGNS & SYMPTOMS
  Increased heart rate and corrected QT interval

 

 Patient/Family Education

  • Explain name, dose, action, and potential side effects of drug.
  • Advise patient to take once daily without regard to meals.
  • Advise patient that if allergy symptoms are not controlled, not to increase the dose of medication or frequency of use but to inform the health care provider. Inform patient that larger or more frequent dosing does not increase effectiveness and may cause drowsiness.
  • Caution patient not to take any otc antihistamines while taking this medication unless advised to do so by the health care provider.
  • If patient is to have allergy skin testing, advise to not take the medication for 6 days or more before the skin testing.
  • Advise patient to notify health care provider if becoming pregnant, planning on becoming pregnant, or breastfeeding.
  • Instruct patient to stop taking drug and immediately report any of the following symptoms to health care provider: dizziness, excessive drowsiness.
  • Caution patient to not take any prescription or otc medications, or dietary supplements unless advised by health care provider.

Indications for Drugs ::

(dess-lore-AT-ah-deen)
Clarinex
Tablets
5 mg
Class: Antihistamine

 

 Action Long-acting histamine antagonist with selective H1-receptor histamine antagonist activity.

 

 Indications Relief of nasal and non-nasal symptoms of seasonal and perennial allergic rhinitis; in chronic idiopathic urticaria for relief of symptoms of pruritus and reduction in number and size of hives.

 

 Contraindications Standard considerations.

 

 Route/Dosage

Adults and Children Older Than 12 Yr: PO 5 mg once daily. In patients with renal or hepatic impairment, start with 5 mg qod.

 

 Interactions None well documented.

 

 Lab Test Interferences None well documented.

 

 Adverse Reactions CARDIOVASCULAR: Tachycardia. CNS: Somnolence; fatigue; dizziness. EENT: Pharyngitis; dry throat. GI: Dry mouth; nausea. HEPATIC: Elevated liver enzymes and bilirubin. OTHER: Flu-like symptoms; myalgia; hypersensitivity.

 

 Precautions

Pregnancy: Category C. Lactation: Excreted in breast milk. Children: Safety and efficacy not established in children less than 12 yr. Elderly: Select dose with caution, reflecting greater frequency of decreased hepatic, renal, or cardiac function and comorbidity. Renal or Hepatic Impairment: Dosage adjustment is recommended.

PATIENT CARE CONSIDERATIONS

 

 Administration/Storage

  • Give once daily without regard to food.
  • Start patients with kidney or liver impairment on 1 tablet qod.
  • Store tablets at controlled room temperature. Keep container tightly closed. Protect unit-dose hospital pack from moisture.

 

 Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies. Note history of hepatic or renal dysfunction.
  • Assess for allergy symptoms (eg, rhinitis, nasal congestion, sneezing, itching, watery eyes) before and periodically throughout therapy.
  • Monitor patient for dizziness and excessive drowsiness. If noted, hold therapy and notify health care provider.
OVERDOSAGE: SIGNS & SYMPTOMS
  Increased heart rate and corrected QT interval

 

 Patient/Family Education

  • Explain name, dose, action, and potential side effects of drug.
  • Advise patient to take once daily without regard to meals.
  • Advise patient that if allergy symptoms are not controlled, not to increase the dose of medication or frequency of use but to inform the health care provider. Inform patient that larger or more frequent dosing does not increase effectiveness and may cause drowsiness.
  • Caution patient not to take any otc antihistamines while taking this medication unless advised to do so by the health care provider.
  • If patient is to have allergy skin testing, advise to not take the medication for 6 days or more before the skin testing.
  • Advise patient to notify health care provider if becoming pregnant, planning on becoming pregnant, or breastfeeding.
  • Instruct patient to stop taking drug and immediately report any of the following symptoms to health care provider: dizziness, excessive drowsiness.
  • Caution patient to not take any prescription or otc medications, or dietary supplements unless advised by health care provider.

Drug Dose ::

(dess-lore-AT-ah-deen)
Clarinex
Tablets
5 mg
Class: Antihistamine

 

 Action Long-acting histamine antagonist with selective H1-receptor histamine antagonist activity.

 

 Indications Relief of nasal and non-nasal symptoms of seasonal and perennial allergic rhinitis; in chronic idiopathic urticaria for relief of symptoms of pruritus and reduction in number and size of hives.

 

 Contraindications Standard considerations.

 

 Route/Dosage

Adults and Children Older Than 12 Yr: PO 5 mg once daily. In patients with renal or hepatic impairment, start with 5 mg qod.

 

 Interactions None well documented.

 

 Lab Test Interferences None well documented.

 

 Adverse Reactions CARDIOVASCULAR: Tachycardia. CNS: Somnolence; fatigue; dizziness. EENT: Pharyngitis; dry throat. GI: Dry mouth; nausea. HEPATIC: Elevated liver enzymes and bilirubin. OTHER: Flu-like symptoms; myalgia; hypersensitivity.

 

 Precautions

Pregnancy: Category C. Lactation: Excreted in breast milk. Children: Safety and efficacy not established in children less than 12 yr. Elderly: Select dose with caution, reflecting greater frequency of decreased hepatic, renal, or cardiac function and comorbidity. Renal or Hepatic Impairment: Dosage adjustment is recommended.

PATIENT CARE CONSIDERATIONS

 

 Administration/Storage

  • Give once daily without regard to food.
  • Start patients with kidney or liver impairment on 1 tablet qod.
  • Store tablets at controlled room temperature. Keep container tightly closed. Protect unit-dose hospital pack from moisture.

 

 Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies. Note history of hepatic or renal dysfunction.
  • Assess for allergy symptoms (eg, rhinitis, nasal congestion, sneezing, itching, watery eyes) before and periodically throughout therapy.
  • Monitor patient for dizziness and excessive drowsiness. If noted, hold therapy and notify health care provider.
OVERDOSAGE: SIGNS & SYMPTOMS
  Increased heart rate and corrected QT interval

 

 Patient/Family Education

  • Explain name, dose, action, and potential side effects of drug.
  • Advise patient to take once daily without regard to meals.
  • Advise patient that if allergy symptoms are not controlled, not to increase the dose of medication or frequency of use but to inform the health care provider. Inform patient that larger or more frequent dosing does not increase effectiveness and may cause drowsiness.
  • Caution patient not to take any otc antihistamines while taking this medication unless advised to do so by the health care provider.
  • If patient is to have allergy skin testing, advise to not take the medication for 6 days or more before the skin testing.
  • Advise patient to notify health care provider if becoming pregnant, planning on becoming pregnant, or breastfeeding.
  • Instruct patient to stop taking drug and immediately report any of the following symptoms to health care provider: dizziness, excessive drowsiness.
  • Caution patient to not take any prescription or otc medications, or dietary supplements unless advised by health care provider.

Contraindication ::

(dess-lore-AT-ah-deen)
Clarinex
Tablets
5 mg
Class: Antihistamine

 

 Action Long-acting histamine antagonist with selective H1-receptor histamine antagonist activity.

 

 Indications Relief of nasal and non-nasal symptoms of seasonal and perennial allergic rhinitis; in chronic idiopathic urticaria for relief of symptoms of pruritus and reduction in number and size of hives.

 

 Contraindications Standard considerations.

 

 Route/Dosage

Adults and Children Older Than 12 Yr: PO 5 mg once daily. In patients with renal or hepatic impairment, start with 5 mg qod.

 

 Interactions None well documented.

 

 Lab Test Interferences None well documented.

 

 Adverse Reactions CARDIOVASCULAR: Tachycardia. CNS: Somnolence; fatigue; dizziness. EENT: Pharyngitis; dry throat. GI: Dry mouth; nausea. HEPATIC: Elevated liver enzymes and bilirubin. OTHER: Flu-like symptoms; myalgia; hypersensitivity.

 

 Precautions

Pregnancy: Category C. Lactation: Excreted in breast milk. Children: Safety and efficacy not established in children less than 12 yr. Elderly: Select dose with caution, reflecting greater frequency of decreased hepatic, renal, or cardiac function and comorbidity. Renal or Hepatic Impairment: Dosage adjustment is recommended.

PATIENT CARE CONSIDERATIONS

 

 Administration/Storage

  • Give once daily without regard to food.
  • Start patients with kidney or liver impairment on 1 tablet qod.
  • Store tablets at controlled room temperature. Keep container tightly closed. Protect unit-dose hospital pack from moisture.

 

 Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies. Note history of hepatic or renal dysfunction.
  • Assess for allergy symptoms (eg, rhinitis, nasal congestion, sneezing, itching, watery eyes) before and periodically throughout therapy.
  • Monitor patient for dizziness and excessive drowsiness. If noted, hold therapy and notify health care provider.
OVERDOSAGE: SIGNS & SYMPTOMS
  Increased heart rate and corrected QT interval

 

 Patient/Family Education

  • Explain name, dose, action, and potential side effects of drug.
  • Advise patient to take once daily without regard to meals.
  • Advise patient that if allergy symptoms are not controlled, not to increase the dose of medication or frequency of use but to inform the health care provider. Inform patient that larger or more frequent dosing does not increase effectiveness and may cause drowsiness.
  • Caution patient not to take any otc antihistamines while taking this medication unless advised to do so by the health care provider.
  • If patient is to have allergy skin testing, advise to not take the medication for 6 days or more before the skin testing.
  • Advise patient to notify health care provider if becoming pregnant, planning on becoming pregnant, or breastfeeding.
  • Instruct patient to stop taking drug and immediately report any of the following symptoms to health care provider: dizziness, excessive drowsiness.
  • Caution patient to not take any prescription or otc medications, or dietary supplements unless advised by health care provider.

Drug Precautions ::

(dess-lore-AT-ah-deen)
Clarinex
Tablets
5 mg
Class: Antihistamine

 

 Action Long-acting histamine antagonist with selective H1-receptor histamine antagonist activity.

 

 Indications Relief of nasal and non-nasal symptoms of seasonal and perennial allergic rhinitis; in chronic idiopathic urticaria for relief of symptoms of pruritus and reduction in number and size of hives.

 

 Contraindications Standard considerations.

 

 Route/Dosage

Adults and Children Older Than 12 Yr: PO 5 mg once daily. In patients with renal or hepatic impairment, start with 5 mg qod.

 

 Interactions None well documented.

 

 Lab Test Interferences None well documented.

 

 Adverse Reactions CARDIOVASCULAR: Tachycardia. CNS: Somnolence; fatigue; dizziness. EENT: Pharyngitis; dry throat. GI: Dry mouth; nausea. HEPATIC: Elevated liver enzymes and bilirubin. OTHER: Flu-like symptoms; myalgia; hypersensitivity.

 

 Precautions

Pregnancy: Category C. Lactation: Excreted in breast milk. Children: Safety and efficacy not established in children less than 12 yr. Elderly: Select dose with caution, reflecting greater frequency of decreased hepatic, renal, or cardiac function and comorbidity. Renal or Hepatic Impairment: Dosage adjustment is recommended.

PATIENT CARE CONSIDERATIONS

 

 Administration/Storage

  • Give once daily without regard to food.
  • Start patients with kidney or liver impairment on 1 tablet qod.
  • Store tablets at controlled room temperature. Keep container tightly closed. Protect unit-dose hospital pack from moisture.

 

 Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies. Note history of hepatic or renal dysfunction.
  • Assess for allergy symptoms (eg, rhinitis, nasal congestion, sneezing, itching, watery eyes) before and periodically throughout therapy.
  • Monitor patient for dizziness and excessive drowsiness. If noted, hold therapy and notify health care provider.
OVERDOSAGE: SIGNS & SYMPTOMS
  Increased heart rate and corrected QT interval

 

 Patient/Family Education

  • Explain name, dose, action, and potential side effects of drug.
  • Advise patient to take once daily without regard to meals.
  • Advise patient that if allergy symptoms are not controlled, not to increase the dose of medication or frequency of use but to inform the health care provider. Inform patient that larger or more frequent dosing does not increase effectiveness and may cause drowsiness.
  • Caution patient not to take any otc antihistamines while taking this medication unless advised to do so by the health care provider.
  • If patient is to have allergy skin testing, advise to not take the medication for 6 days or more before the skin testing.
  • Advise patient to notify health care provider if becoming pregnant, planning on becoming pregnant, or breastfeeding.
  • Instruct patient to stop taking drug and immediately report any of the following symptoms to health care provider: dizziness, excessive drowsiness.
  • Caution patient to not take any prescription or otc medications, or dietary supplements unless advised by health care provider.

Drug Side Effects ::

(dess-lore-AT-ah-deen)
Clarinex
Tablets
5 mg
Class: Antihistamine

 

 Action Long-acting histamine antagonist with selective H1-receptor histamine antagonist activity.

 

 Indications Relief of nasal and non-nasal symptoms of seasonal and perennial allergic rhinitis; in chronic idiopathic urticaria for relief of symptoms of pruritus and reduction in number and size of hives.

 

 Contraindications Standard considerations.

 

 Route/Dosage

Adults and Children Older Than 12 Yr: PO 5 mg once daily. In patients with renal or hepatic impairment, start with 5 mg qod.

 

 Interactions None well documented.

 

 Lab Test Interferences None well documented.

 

 Adverse Reactions CARDIOVASCULAR: Tachycardia. CNS: Somnolence; fatigue; dizziness. EENT: Pharyngitis; dry throat. GI: Dry mouth; nausea. HEPATIC: Elevated liver enzymes and bilirubin. OTHER: Flu-like symptoms; myalgia; hypersensitivity.

 

 Precautions

Pregnancy: Category C. Lactation: Excreted in breast milk. Children: Safety and efficacy not established in children less than 12 yr. Elderly: Select dose with caution, reflecting greater frequency of decreased hepatic, renal, or cardiac function and comorbidity. Renal or Hepatic Impairment: Dosage adjustment is recommended.

PATIENT CARE CONSIDERATIONS

 

 Administration/Storage

  • Give once daily without regard to food.
  • Start patients with kidney or liver impairment on 1 tablet qod.
  • Store tablets at controlled room temperature. Keep container tightly closed. Protect unit-dose hospital pack from moisture.

 

 Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies. Note history of hepatic or renal dysfunction.
  • Assess for allergy symptoms (eg, rhinitis, nasal congestion, sneezing, itching, watery eyes) before and periodically throughout therapy.
  • Monitor patient for dizziness and excessive drowsiness. If noted, hold therapy and notify health care provider.
OVERDOSAGE: SIGNS & SYMPTOMS
  Increased heart rate and corrected QT interval

 

 Patient/Family Education

  • Explain name, dose, action, and potential side effects of drug.
  • Advise patient to take once daily without regard to meals.
  • Advise patient that if allergy symptoms are not controlled, not to increase the dose of medication or frequency of use but to inform the health care provider. Inform patient that larger or more frequent dosing does not increase effectiveness and may cause drowsiness.
  • Caution patient not to take any otc antihistamines while taking this medication unless advised to do so by the health care provider.
  • If patient is to have allergy skin testing, advise to not take the medication for 6 days or more before the skin testing.
  • Advise patient to notify health care provider if becoming pregnant, planning on becoming pregnant, or breastfeeding.
  • Instruct patient to stop taking drug and immediately report any of the following symptoms to health care provider: dizziness, excessive drowsiness.
  • Caution patient to not take any prescription or otc medications, or dietary supplements unless advised by health care provider.

Drug Mode of Action ::  

(dess-lore-AT-ah-deen)
Clarinex
Tablets
5 mg
Class: Antihistamine

 

 Action Long-acting histamine antagonist with selective H1-receptor histamine antagonist activity.

 

 Indications Relief of nasal and non-nasal symptoms of seasonal and perennial allergic rhinitis; in chronic idiopathic urticaria for relief of symptoms of pruritus and reduction in number and size of hives.

 

 Contraindications Standard considerations.

 

 Route/Dosage

Adults and Children Older Than 12 Yr: PO 5 mg once daily. In patients with renal or hepatic impairment, start with 5 mg qod.

 

 Interactions None well documented.

 

 Lab Test Interferences None well documented.

 

 Adverse Reactions CARDIOVASCULAR: Tachycardia. CNS: Somnolence; fatigue; dizziness. EENT: Pharyngitis; dry throat. GI: Dry mouth; nausea. HEPATIC: Elevated liver enzymes and bilirubin. OTHER: Flu-like symptoms; myalgia; hypersensitivity.

 

 Precautions

Pregnancy: Category C. Lactation: Excreted in breast milk. Children: Safety and efficacy not established in children less than 12 yr. Elderly: Select dose with caution, reflecting greater frequency of decreased hepatic, renal, or cardiac function and comorbidity. Renal or Hepatic Impairment: Dosage adjustment is recommended.

PATIENT CARE CONSIDERATIONS

 

 Administration/Storage

  • Give once daily without regard to food.
  • Start patients with kidney or liver impairment on 1 tablet qod.
  • Store tablets at controlled room temperature. Keep container tightly closed. Protect unit-dose hospital pack from moisture.

 

 Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies. Note history of hepatic or renal dysfunction.
  • Assess for allergy symptoms (eg, rhinitis, nasal congestion, sneezing, itching, watery eyes) before and periodically throughout therapy.
  • Monitor patient for dizziness and excessive drowsiness. If noted, hold therapy and notify health care provider.
OVERDOSAGE: SIGNS & SYMPTOMS
  Increased heart rate and corrected QT interval

 

 Patient/Family Education

  • Explain name, dose, action, and potential side effects of drug.
  • Advise patient to take once daily without regard to meals.
  • Advise patient that if allergy symptoms are not controlled, not to increase the dose of medication or frequency of use but to inform the health care provider. Inform patient that larger or more frequent dosing does not increase effectiveness and may cause drowsiness.
  • Caution patient not to take any otc antihistamines while taking this medication unless advised to do so by the health care provider.
  • If patient is to have allergy skin testing, advise to not take the medication for 6 days or more before the skin testing.
  • Advise patient to notify health care provider if becoming pregnant, planning on becoming pregnant, or breastfeeding.
  • Instruct patient to stop taking drug and immediately report any of the following symptoms to health care provider: dizziness, excessive drowsiness.
  • Caution patient to not take any prescription or otc medications, or dietary supplements unless advised by health care provider.

Drug Interactions ::

(dess-lore-AT-ah-deen)
Clarinex
Tablets
5 mg
Class: Antihistamine

 

 Action Long-acting histamine antagonist with selective H1-receptor histamine antagonist activity.

 

 Indications Relief of nasal and non-nasal symptoms of seasonal and perennial allergic rhinitis; in chronic idiopathic urticaria for relief of symptoms of pruritus and reduction in number and size of hives.

 

 Contraindications Standard considerations.

 

 Route/Dosage

Adults and Children Older Than 12 Yr: PO 5 mg once daily. In patients with renal or hepatic impairment, start with 5 mg qod.

 

 Interactions None well documented.

 

Drug Assesment ::

(dess-lore-AT-ah-deen)
Clarinex
Tablets
5 mg
Class: Antihistamine

 

 Action Long-acting histamine antagonist with selective H1-receptor histamine antagonist activity.

 

 Indications Relief of nasal and non-nasal symptoms of seasonal and perennial allergic rhinitis; in chronic idiopathic urticaria for relief of symptoms of pruritus and reduction in number and size of hives.

 

 Contraindications Standard considerations.

 

 Route/Dosage

Adults and Children Older Than 12 Yr: PO 5 mg once daily. In patients with renal or hepatic impairment, start with 5 mg qod.

 

 Interactions None well documented.

 

 Lab Test Interferences None well documented.

 

 Adverse Reactions CARDIOVASCULAR: Tachycardia. CNS: Somnolence; fatigue; dizziness. EENT: Pharyngitis; dry throat. GI: Dry mouth; nausea. HEPATIC: Elevated liver enzymes and bilirubin. OTHER: Flu-like symptoms; myalgia; hypersensitivity.

 

 Precautions

Pregnancy: Category C. Lactation: Excreted in breast milk. Children: Safety and efficacy not established in children less than 12 yr. Elderly: Select dose with caution, reflecting greater frequency of decreased hepatic, renal, or cardiac function and comorbidity. Renal or Hepatic Impairment: Dosage adjustment is recommended.

PATIENT CARE CONSIDERATIONS

 

 Administration/Storage

  • Give once daily without regard to food.
  • Start patients with kidney or liver impairment on 1 tablet qod.
  • Store tablets at controlled room temperature. Keep container tightly closed. Protect unit-dose hospital pack from moisture.

 

 Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies. Note history of hepatic or renal dysfunction.
  • Assess for allergy symptoms (eg, rhinitis, nasal congestion, sneezing, itching, watery eyes) before and periodically throughout therapy.
  • Monitor patient for dizziness and excessive drowsiness. If noted, hold therapy and notify health care provider.
OVERDOSAGE: SIGNS & SYMPTOMS
  Increased heart rate and corrected QT interval

 

 Patient/Family Education

  • Explain name, dose, action, and potential side effects of drug.
  • Advise patient to take once daily without regard to meals.
  • Advise patient that if allergy symptoms are not controlled, not to increase the dose of medication or frequency of use but to inform the health care provider. Inform patient that larger or more frequent dosing does not increase effectiveness and may cause drowsiness.
  • Caution patient not to take any otc antihistamines while taking this medication unless advised to do so by the health care provider.
  • If patient is to have allergy skin testing, advise to not take the medication for 6 days or more before the skin testing.
  • Advise patient to notify health care provider if becoming pregnant, planning on becoming pregnant, or breastfeeding.
  • Instruct patient to stop taking drug and immediately report any of the following symptoms to health care provider: dizziness, excessive drowsiness.
  • Caution patient to not take any prescription or otc medications, or dietary supplements unless advised by health care provider.

Drug Storage/Management ::

(dess-lore-AT-ah-deen)
Clarinex
Tablets
5 mg
Class: Antihistamine

 

 Action Long-acting histamine antagonist with selective H1-receptor histamine antagonist activity.

 

 Indications Relief of nasal and non-nasal symptoms of seasonal and perennial allergic rhinitis; in chronic idiopathic urticaria for relief of symptoms of pruritus and reduction in number and size of hives.

 

 Contraindications Standard considerations.

 

 Route/Dosage

Adults and Children Older Than 12 Yr: PO 5 mg once daily. In patients with renal or hepatic impairment, start with 5 mg qod.

 

 Interactions None well documented.

 

 Lab Test Interferences None well documented.

 

 Adverse Reactions CARDIOVASCULAR: Tachycardia. CNS: Somnolence; fatigue; dizziness. EENT: Pharyngitis; dry throat. GI: Dry mouth; nausea. HEPATIC: Elevated liver enzymes and bilirubin. OTHER: Flu-like symptoms; myalgia; hypersensitivity.

 

 Precautions

Pregnancy: Category C. Lactation: Excreted in breast milk. Children: Safety and efficacy not established in children less than 12 yr. Elderly: Select dose with caution, reflecting greater frequency of decreased hepatic, renal, or cardiac function and comorbidity. Renal or Hepatic Impairment: Dosage adjustment is recommended.

PATIENT CARE CONSIDERATIONS

 

 Administration/Storage

  • Give once daily without regard to food.
  • Start patients with kidney or liver impairment on 1 tablet qod.
  • Store tablets at controlled room temperature. Keep container tightly closed. Protect unit-dose hospital pack from moisture.

 

 Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies. Note history of hepatic or renal dysfunction.
  • Assess for allergy symptoms (eg, rhinitis, nasal congestion, sneezing, itching, watery eyes) before and periodically throughout therapy.
  • Monitor patient for dizziness and excessive drowsiness. If noted, hold therapy and notify health care provider.
OVERDOSAGE: SIGNS & SYMPTOMS
  Increased heart rate and corrected QT interval

 

 Patient/Family Education

  • Explain name, dose, action, and potential side effects of drug.
  • Advise patient to take once daily without regard to meals.
  • Advise patient that if allergy symptoms are not controlled, not to increase the dose of medication or frequency of use but to inform the health care provider. Inform patient that larger or more frequent dosing does not increase effectiveness and may cause drowsiness.
  • Caution patient not to take any otc antihistamines while taking this medication unless advised to do so by the health care provider.
  • If patient is to have allergy skin testing, advise to not take the medication for 6 days or more before the skin testing.
  • Advise patient to notify health care provider if becoming pregnant, planning on becoming pregnant, or breastfeeding.
  • Instruct patient to stop taking drug and immediately report any of the following symptoms to health care provider: dizziness, excessive drowsiness.
  • Caution patient to not take any prescription or otc medications, or dietary supplements unless advised by health care provider.

Drug Notes ::

(dess-lore-AT-ah-deen)
Clarinex
Tablets
5 mg
Class: Antihistamine

 

 Action Long-acting histamine antagonist with selective H1-receptor histamine antagonist activity.

 

 Indications Relief of nasal and non-nasal symptoms of seasonal and perennial allergic rhinitis; in chronic idiopathic urticaria for relief of symptoms of pruritus and reduction in number and size of hives.

 

 Contraindications Standard considerations.

 

 Route/Dosage

Adults and Children Older Than 12 Yr: PO 5 mg once daily. In patients with renal or hepatic impairment, start with 5 mg qod.

 

 Interactions None well documented.

 

 Lab Test Interferences None well documented.

 

 Adverse Reactions CARDIOVASCULAR: Tachycardia. CNS: Somnolence; fatigue; dizziness. EENT: Pharyngitis; dry throat. GI: Dry mouth; nausea. HEPATIC: Elevated liver enzymes and bilirubin. OTHER: Flu-like symptoms; myalgia; hypersensitivity.

 

 Precautions

Pregnancy: Category C. Lactation: Excreted in breast milk. Children: Safety and efficacy not established in children less than 12 yr. Elderly: Select dose with caution, reflecting greater frequency of decreased hepatic, renal, or cardiac function and comorbidity. Renal or Hepatic Impairment: Dosage adjustment is recommended.

PATIENT CARE CONSIDERATIONS

 

 Administration/Storage

  • Give once daily without regard to food.
  • Start patients with kidney or liver impairment on 1 tablet qod.
  • Store tablets at controlled room temperature. Keep container tightly closed. Protect unit-dose hospital pack from moisture.

 

 Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies. Note history of hepatic or renal dysfunction.
  • Assess for allergy symptoms (eg, rhinitis, nasal congestion, sneezing, itching, watery eyes) before and periodically throughout therapy.
  • Monitor patient for dizziness and excessive drowsiness. If noted, hold therapy and notify health care provider.
OVERDOSAGE: SIGNS & SYMPTOMS
  Increased heart rate and corrected QT interval

 

 Patient/Family Education

  • Explain name, dose, action, and potential side effects of drug.
  • Advise patient to take once daily without regard to meals.
  • Advise patient that if allergy symptoms are not controlled, not to increase the dose of medication or frequency of use but to inform the health care provider. Inform patient that larger or more frequent dosing does not increase effectiveness and may cause drowsiness.
  • Caution patient not to take any otc antihistamines while taking this medication unless advised to do so by the health care provider.
  • If patient is to have allergy skin testing, advise to not take the medication for 6 days or more before the skin testing.
  • Advise patient to notify health care provider if becoming pregnant, planning on becoming pregnant, or breastfeeding.
  • Instruct patient to stop taking drug and immediately report any of the following symptoms to health care provider: dizziness, excessive drowsiness.
  • Caution patient to not take any prescription or otc medications, or dietary supplements unless advised by health care provider.

Disclaimer ::

The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.
Tags:

Leave a comment

Your email address will not be published. Required fields are marked *

royalmpo Royalmpo Royalmpo royalmpo royalmpo royalmpo royalmpo https://malangtoday.id/ https://guyonanbola.com/ renunganhariankatolik.web.id royalmpo royalmpo royalmpo dewaslot168 ri188 https://hayzlett.com/c-suite-network/ kingslot jkt88 mpodewa https://going-natural.com/the-story-behind-the-mutilated-scalp-video/ royalmpo/ pisang88/ langkahcurang/ mpohoki/ mpocuan/ royalmpo/ mporoyal/ asiaslot/ rajaslot138/ royalmpo https://hayzlett.com/news/ rajaslot88/ Analisis Scatter Hitam MahjongWays RTP Terukur Kemenangan Puluhan Grid Fase Awal Mahjong Pola Perilaku Pemain Harian Prediksi Strategi Game Terbaik RTP Strategi Target Kemenangan Tekanan Meja Live Kasino Slot Digital Hiburan Ringan Slot Online Tanpa Target Mengelola Mood Pemain Slot https://going-natural.com/my-braid-locs/ https://going-natural.com/kellen-marcus/ narutoslot bangslot royalmpo royalmpo macanasia bosslot slotking gacorway
Strategi Analitik Platform Game Dalam Mengelola Variasi Pola Permainan Online Di Era Windows 12 Pendekatan Data Driven Dalam Memahami Ritme Sistem Permainan Digital Pada Ekosistem Android Modern Studi Dinamika Platform Gaming Melalui Distribusi Kombinasi Simbol Di Tengah Popularitas Xbox Game Pass Analisis Strategi Modern Dalam Mengelola Volatilitas Sistem Permainan Digital Saat Tren Nintendo Kembali Naik Framework Pengolahan Data Gaming Untuk Menjaga Stabilitas Pola Permainan Dalam Era Gemini AI Tools Teori Permainan Mahjong Ways Dalam Analisa Intensitas Sistem RTP Online Pada Perangkat Smartphone Modern Pendekatan Sistematis Dalam Menganalisis Pola Permainan Pada Ekosistem Gaming Setelah Discord Down Model Evaluasi Strategi Platform Game Melalui Observasi Pergerakan Algoritma Setelah Update iOS 26.3.1 Strategi Adaptif Dalam Mengelola Ritme Permainan Pada Platform Digital Dengan Dukungan Windows 12 Pendekatan Data Analitik Untuk Mengidentifikasi Pola Sistem Permainan Mobile Pada Samsung Galaxy S26 Ultra
Studi Adaptasi Strategi Permainan Mahjong Dalam Sistem Platform Digital Di Tengah Tren Nintendo Gaming Analisis Teknologi Gaming Platform Dalam Evolusi Sistem Permainan Berbasis RTP Di Era Gemini AI Pendekatan Sistematik Dalam Analisis Algoritma Permainan Mobile Saat Dark Mode Twitter Kembali Trending Studi Pola Mahjong Ways Dalam Perspektif Strategi Platform Game Pada Perangkat Smartphone Modern Analisis Perkembangan Algoritma Platform Gaming Dalam Sistem Permainan Pada Era Xbox Game Pass Pendekatan Manajemen Risiko Permainan Mobile Dalam Ekosistem Gaming Android Generasi Baru Strategi Pengamatan Sistem Permainan Dalam Lingkungan Platform Game Modern Saat Windows 12 Dibahas Evaluasi Sistem Gaming Platform Dalam Mengelola Variasi Pola Permainan Pada Perangkat Samsung Galaxy Framework Analitik Permainan Digital Dalam Mengelola Variasi Sistem Game Saat Re9 Update Dibahas Gamer Studi Dinamika Platform Game Melalui Pendekatan Analisis Data Di Era Apple Newsroom Digital Model Framework Strategi Permainan Digital Dalam Platform Gaming Berbasis Android Modern Strategi Pengelolaan Sistem Permainan Melalui Pendekatan Data Analitik Pada Infrastruktur Cloud Gaming Analisis Adaptasi Sistem Permainan Dalam Ekosistem Gaming Digital Saat Project Helix Menjadi Sorotan Pendekatan Modern Dalam Analisis Pola Permainan Berbasis Data Saat Gemini AI Digunakan Developer Evaluasi Dinamika Sistem Permainan Digital Melalui Observasi Data Pada Sistem iOS 26.3.1 Studi Struktur Sistem Game Dalam Perspektif Teknologi Gaming Di Tengah Tren Nintendo Global Pendekatan Framework Gaming Dalam Mengelola Pola Permainan Digital Di Tengah Popularitas Mario Day Analisis Perubahan Pola Mahjong Wins Dalam Ekosistem Gaming Modern Saat Re9 Update Diperbincangkan Model Analitik Pola Permainan Mahjong Dalam Sistem Platform Digital Modern Berbasis Android Studi Evolusi Teknologi Gaming Dalam Pengembangan Platform Permainan Pada Sistem Windows 12 Strategi Modern Membaca Sistem Permainan Digital Berbasis Algoritma Pada Infrastruktur Cloud Gaming Evaluasi Sistem Platform Game Dalam Dinamika Permainan Online Pada Era Smartphone Modern Pendekatan Data Platform Dalam Mengidentifikasi Pola Permainan Online Pada Infrastruktur TV App Strategi Pengolahan Data Gaming Dalam Mengelola Pola Permainan RTP Pada Infrastruktur Gaming Cloud Strategi Pengelolaan Pola Permainan Melalui Analisis Platform Digital Saat iPhone Generasi Baru Dirilis Pendekatan Analitik Sistem Game Dalam Mengelola Ritme Permainan Pada Era Xbox Game Pass Strategi Data Driven Dalam Menganalisis Pola Sistem Permainan Digital Pada Infrastruktur Cloud Studi Algoritma Permainan Mahjong Dalam Perspektif Platform Gaming Pada Ekosistem Android Analisis Sistem Permainan Digital Dalam Kerangka Strategi Platform Game Di Era Apple Ecosystem Dinamika Sistem Permainan Mahjong Digital Melalui Observasi Ritme Algoritma Pada Ekosistem Gaming Mobile Modern Pola Mahjong Ways 2 Hari Ini Strategi Malam Mahjong Wins 3 Kisah Sukses Andi Grid Mahjong & Starlight Saksi Mata: Mode Manual Mahjong Wins RTP Bertahap Pragmatic Spiral Pola Mahjong Ways Kurikulum Jackpot Respon Mahjong Wins 3 Lebih Cepat Akselerasi Free Spin Mahjong Wins3